Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study

被引:4
作者
Millar, John [1 ]
McNamee, Paul [2 ]
Heaney, David [3 ]
Selvaraj, Sivasubramaniam [3 ]
Bond, Christine [4 ]
Lindsay, Sandra [3 ]
Morton, Mary [5 ]
机构
[1] Dingwall Med Grp Hlth Ctr, Dingwall IV15 9QS, Ross Shire, Scotland
[2] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen AB28 2ZD, Scotland
[3] Univ Aberdeen, Ctr Hlth Sci, Ctr Rural Hlth, Inverness IV3 3JH, Scotland
[4] Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen, Scotland
[5] NHS Highland, John Dewar House, Inverness IV2 7GE, Scotland
关键词
Family medicine; health economics; pharmacy; prescribing; randomized controlled trial; ADVERSE DRUG-REACTIONS;
D O I
10.1093/fampra/cmn100
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. In view of the increasing cost of general practice of drug prescribing, it is important to look at ways of reducing drug wastage and thereby improve the cost-effectiveness of prescribing. Objective. To determine the costs and cost savings to the NHS of instalment dispensing for newly prescribed medicines and to quantify the extra costs incurred by patients. Methods. Patients were randomized to receive either a normal (n = 103) or an instalment (n = 101) prescription. Results. The difference between prescribed and dispensed drug costs in the intervention group was 0.98 pound per patient (95% confidence interval 0.14- pound 1.82) pound, giving a 7% reduction in drug costs. The costs of the additional pharmacy time required to implement the intervention was calculated to be 5.02 pound per patient. Conclusions. Introduction of a system of instalment dispensing produced savings in the general practice of drugs bill, but these were not large enough to offset additional costs for pharmacists.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 12 条
  • [1] ALTMAN DG, 1996, BRIT MED J, V313, P550
  • [2] A review of the literature on the economics of noncompliance. Room for methodological improvement
    Cleemput, I
    Kesteloot, K
    DeGeest, S
    [J]. HEALTH POLICY, 2002, 59 (01) : 65 - 94
  • [3] Is adherence to drug treatment correlated with health-related quality of life?
    Côté, I
    Farris, K
    Feeny, D
    [J]. QUALITY OF LIFE RESEARCH, 2003, 12 (06) : 621 - 633
  • [4] CURTIS L, 2004, UNIT COSTS HLTH SOCI, P119
  • [5] Hawksworth G., 1996, J SOC ADMIN PHARM, V13, P215
  • [6] The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease
    Jaffray, Mariesha
    Bond, Christine
    Watson, Margaret
    Hannaford, Philip
    Tinelli, Michela
    Scott, Anthony
    Lee, Amanda
    Blenkinsopp, Alison
    Anderson, Claire
    Avery, Anthony
    Bissell, Paul
    Krska, Janet
    [J]. FAMILY PRACTICE, 2007, 24 (02) : 189 - 200
  • [7] Millar J, 2003, BRIT J GEN PRACT, V53, P550
  • [8] Millar JS, 2001, BRIT J GEN PRACT, V51, P130
  • [9] MISTRY H, 2005, EUR J HEALTH ECON, V50, P261
  • [10] The accuracy of self-reported healthcare resource utilization in health economic studies
    Petrou, S
    Murray, L
    Cooper, P
    Davidson, LL
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 705 - 710